Coffey McPharlin is now investigating and accepting cases involving Zofran birth defects. Zofran (ondansetron), is a medication that is approved by the U.S. Food and Drug Administration to be prescribed to cancer patients undergoing chemotherapy or radiation therapy to combat symptoms of nausea asdociated with therapy. This medicine has also been prescribed “off-label” by OBGYNs … Continue reading “Zofran Birth Defect Lawsuit”